SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-15-368267
Filing Date
2015-11-05
Accepted
2015-11-05 16:07:12
Documents
3
Period of Report
2015-11-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d34303d8k.htm 8-K 12426
2 EX-99.1 d34303dex991.htm EX-99.1 59293
3 GRAPHIC g34303snap1.jpg GRAPHIC 14462
  Complete submission text file 0001193125-15-368267.txt   93112
Mailing Address NATL INST FOR BIOPROCESSING RESEARCH FOSTERS AVENUE, MOUNT MERRION BLACKROCK CO. DUBLIN L2 00000
Business Address NATL INST FOR BIOPROCESSING RESEARCH FOSTERS AVENUE, MOUNT MERRION BLACKROCK CO. DUBLIN L2 00000 353 1 215 8100
Nexvet Biopharma plc (Filer) CIK: 0001618561 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-36828 | Film No.: 151200648
SIC: 2834 Pharmaceutical Preparations